Soliton, Inc. (SOLY) Financial Analysis & Valuation | Quarter Chart
Soliton, Inc. (SOLY)
SOLYPrice: $22.58
Fair Value: 🔒
🔒score
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The ... more
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary ra... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Christopher C. Capelli |
| IPO Date | 2019-02-19 | CAGR | — |
| Employees | 13 | Website | www.soliton.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
SOLY chart loading...
Fundamentals
Technicals
| Enterprise Value | $416.38M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 15.37 |
| P/CF Ratio | -41.42 | P/FCF Ratio | — |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | -0.7% | ROA | -0.43% |
| ROCE | -0.46% | Current Ratio | 11.44 |
| Quick Ratio | 11.31 | Cash Ratio | 11.19 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | — | Piotroski Score | — |